uniQure Provides Update on Low-Dose Cohort in P-I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
June 23, 2022
uniQure Reports Completion of Patient Enrollment in the First Two Cohorts of P-I/II Trial for AMT-130 to Treat Huntington’s Diseas...
March 22, 2022
uniQure Reports First Patient Dosing of AMT-130 in P-Ib/II Trial for the Treatment of Huntington’s Disease
February 8, 2022
No more records!
Incisive News in 3 Shots.
First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2022 PharmaShots - All Rights Reserved.